Medications Development for Drug Abuse Disorders

Trial Profile

Medications Development for Drug Abuse Disorders

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Jul 2017

At a glance

  • Drugs Tramadol (Primary) ; Buprenorphine/naloxone; Clonidine
  • Indications Opioid abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Jul 2017 Primary endpoint (Mean Ratings on Clinical Opiate Withdrawal Scale (COWS) Measure of Withdrawal During Double-blind Taper (7-days) and Post-taper (7-days) Period) has been met according to results published in the JAMA Psychiatry.
    • 21 Jul 2017 New trial record
    • 12 Jul 2017 Results published in the JAMA Psychiatry
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top